[Significance of bronchospasm in the development of bronchial obstruction in exogenous allergic alveolitis].
In 22 patients with exogenous allergic alveolitis, VC, FVC, FEV1/VC%, PEF, MEF25, MEF50, MEF75 were determined before and after inhalation of berotec in 1 dose and antrovent in 1 dose. Bronchospasm was detected in 50% of patients. Bronchial spasm was the sole cause of bronchial obstruction in 18.2% of patients and a cause of this disorder in 31.8%. The contribution of bronchospasm to the development of bronchial obstruction was decisive in most patients. In 42% of patients, the proportion of the former in bronchial obstruction amounted to 61-100%.
Nefedov
V B
VB
Popova
L A
LA
D000328:Adult; D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000503:physiopathology*; D001986:Bronchial Spasm / Q000175:diagnosis* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D012129:Respiratory Function Tests
D001993:Bronchodilator Agents; D005280:Fenoterol; D009241:Ipratropium
Znachenie bronkhospazma v narushenii bronkhial'noĭ prokhodimosti pri ékzogennom allergicheskom al'veolite.